Physician profile
Michael A Register
NPI 1174675748
$459.32
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $239 · 2021: $57.93 · 2022: $39.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $121.19 | 2019-2020 | |
| Lilly USA, LLC | $73.80 | 2020-2021 | |
| Allergan, INC. | $51.70 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $42.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.84 | 2020 | |
| Abbvie INC. | $22.96 | 2022 | |
| Merck Sharp & Dohme LLC | $18.90 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.34 | 2021 | |
| Ironshore Pharmaceuticals INC. | $17.97 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.69 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.68 | 2019 | |
| Novo Nordisk INC | $13.12 | 2020 | |
| Avanir Pharmaceuticals, INC. | $11.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Register listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.